The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Open accessAbstract
Natural killer (NK) cells were originally defined as effector lymphocytes of innate immunity endowed with constitutive cytolytic functions. More recently, a more nuanced view of NK cells has emerged. NK cells are now recognized to express a repertoire of activating and inhibitory receptors that is calibrated to ensure self-tolerance while allowing efficacy against assaults such as viral infection and tumor development. Moreover, NK cells do not react in an invariant manner but rather adapt to their environment. Finally, recent studies have unveiled that NK cells can also mount a form of antigen-specific immunologic memory. NK cells thus exert sophisticated biological functions that are attributes of both innate and adaptive immunity, blurring the functional borders between these two arms of the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Depending on the ligands expressed by the tumor cells studied, different NK-activating receptors may be engaged and trigger cytotoxicity (Vivier et al., 2011).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Vivier et al., 2011
In the citing paper
“Further analysis showed that the translocation of E. hirae to secondary lymphoid organs could exert an adjuvant impact on systemic and local immune responses mediated by CTX [2].”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Lanier, L. L. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,765
Self-citationSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,333
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Self-citationMiller, J. S., Soignier, Y., Panoskaltsis‐Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D. H., Le, C. T., DeFor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,894
Kiessling, R. W., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,827
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,773
Self-citationAdaptive Immune Features of Natural Killer Cells
Sun, J. C., Beilke, J., & Lanier, L. (2009) · Nature · doi:10.1038/nature07665 · Cited by 1,647
Self-citationHerberman, R. B., Nunn, M. E., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160204 · Cited by 1,356
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martin‐Fontecha, A., Thomsen, L. L., Brett, S. J., Gerard, C. J., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,351
Cited by
Sorted by citations
Items 501–600 of 1,003
Mapping of NKp46+ Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues
Tomasello, E., Yessaad, N., Grégoire, E., Hudspeth, K. L., Luci, C., Mavilio, D., Hardwigsen, J., & Vivier, É. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00344 · Cited by 74
Zhang, P., Lu, X., Tao, K., Shi, L., Li, W., Wang, G., & Wu, K. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.09.035 · Cited by 74
Montaldo, E., Vitale, C., Cottalasso, F., Conte, R., Glatzer, T., Ambrosini, P., Moretta, L., & Mingari, M. C. (2012) · Blood · doi:10.1182/blood-2011-09-379693 · Cited by 81
Watzl, C. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00005-4 · Cited by 73
Innate and Adaptive Immune Responses in Chronic HCV Infection
Dustin, L. B. (2015) · Current Drug Targets · doi:10.2174/1389450116666150825110532 · Cited by 72
Oberschmidt, O., Morgan, M. A., Huppert, V., Kessler, J., Gardlowski, T., Matthies, N., Aleksandrova, K., Arseniev, L., Schambach, A., Koehl, U., et al. (2019) · Human Gene Therapy Methods · doi:10.1089/hgtb.2019.039 · Cited by 75
Lian, J., Liang, Y., Zhang, H., Lan, M., Ye, Z., Lin, B., Qiu, X., & Zeng, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912279 · Cited by 75
Immune dysfunction in Niemann‐Pick disease type C
Platt, N., Speak, A. O., Colaço, A., Gray, J., Smith, D. A., Williams, I. M., Wallom, K., & Platt, F. M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13138 · Cited by 73
Natural Killer Cells Eradicate Galectin-1–Deficient Glioma in the Absence of Adaptive Immunity
Baker, G. J., Chockley, P. J., Yadav, V. N., Doherty, R. E., Ritt, M., Sivaramakrishnan, S., Castro, M. G., & Lowenstein, P. R. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1203 · Cited by 74
Protective Immunity against Experimental Pulmonary Cryptococcosis in T Cell-Depleted Mice
Wozniak, K. L., Young, M. L., & Wormley, F. L. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00036-11 · Cited by 72
Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells
Schlums, H., Jung, M., Han, H., Theorell, J., Bigley, V., Chiang, S. C. C., Allan, D., Davidson-Moncada, J. K., Dickinson, R. E., Holmes, T. D., et al. (2017) · Blood · doi:10.1182/blood-2016-08-734236 · Cited by 72
Role of natural killer cells in lung cancer
Aktaş, O. N., Öztürk, A. B., Erman, B., Erus, S., Tanju, S., & Dilege, Ş. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2635-3 · Cited by 72
Xu, S., Hu, H.-T., Li, H. L., & Chang, S. (2019) · Cells · doi:10.3390/cells8101140 · Cited by 73
Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury
Calabrese, D. R., Aminian, E., Mallavia, B., Liu, F., Cleary, S. J., Aguilar, O. A., Wang, P., Singer, J. P., Hays, S. R., Golden, J. A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137047 · Cited by 72
Self-citationTyrosine Kinase Btk Is Required for NK Cell Activation
Bao, Y., Zheng, J. H., Han, C., Jin, J., Han, H., Liu, Y., Lau, Y., Tu, W., & Cao, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372425 · Cited by 73
ILC1s in Tissue Inflammation and Infection
Fuchs, A. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00104 · Cited by 78
Parodi, M., Favoreel, H., Candiano, G., Gaggero, S., Sivori, S., Mingari, M., Moretta, L., Vitale, M., & Cantoni, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00719 · Cited by 67
Widowati, W., Jasaputra, D. K., Sumitro, S. B., Widodo, M. A., Mozef, T., Rizal, R., Kusuma, H. S. W., Laksmıtawatı, D. R., Murti, H., Bachtiar, I., et al. (2020) · African Health Sciences · doi:10.4314/ahs.v20i2.36 · Cited by 76
Riise, R. E., Bernson, E., Aurelius, J., Martner, A., Pesce, S., Chiesa, M. D., Marcenaro, E., Bylund, J., Hellstrand, K., Moretta, L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500709 · Cited by 71
Self-citationSato, N., Stringaris, K., Davidson-Moncada, J. K., Reger, R. N., Adler, S., Dunbar, C. E., Choyke, P. L., & Childs, R. W. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2897 · Cited by 71
Lymphoid Regeneration from Gene-Corrected SCID-X1 Subject-Derived iPSCs
Menon, T., Firth, A. L., Scripture-Adams, D. D., Galić, Z., Qualls, S. J., Gilmore, W. B., Ke, E., Singer, O., Anderson, L., Bornzin, A. R., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.02.005 · Cited by 71
Modulation of innate immunity in the tumor microenvironment
González-Gugel, E., Saxena, M., & Bhardwaj, N. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1859-9 · Cited by 69
Antibody-dependent cellular cytotoxicity and influenza virus
Vanderven, H. A., Jegaskanda, S., Wheatley, A. K., & Kent, S. J. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.12.002 · Cited by 70
Luo, G., Sun, Y., Huang, L., Su, Y., Zhao, L., Qin, Y., Xu, X., & Yan, Q. (2019) · Environmental Microbiology · doi:10.1111/1462-2920.14884 · Cited by 69
Helper-like Innate Lymphoid Cells in Humans and Mice
Guia, S., & Narni-Mancinelli, É. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.03.002 · Cited by 76
Sajid, M., Liu, L., & Sun, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.887186 · Cited by 71
IFN‐λ‐mediated IL‐12 production in macrophages induces IFN‐γ production in human NK cells
de Groen, R. A., Boltjes, A., Hou, J., Liu, B., McPhee, F., Friborg, J., Janssen, H. L. A., & Boonstra, A. (2014) · European Journal of Immunology · doi:10.1002/eji.201444903 · Cited by 70
Heylen, M., Ruyssers, N. E., Gielis, E. M., Vanhomwegen, E., Pelckmans, P. A., Moreels, T. G., Man, J. G. D., & Winter, B. Y. D. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.011 · Cited by 71
Zhao, H., Li, Y., Wang, Y., Zhang, J., Ouyang, X., Peng, R., & Yang, J. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.05.018 · Cited by 70
Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR)
Honjo, K., Kubagawa, Y., Jones, D., Dizon, B. L. P., Zhu, Z., Ohno, H., Izui, S., Kearney, J. F., & Kubagawa, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206567109 · Cited by 70
Rölle, A., Halenius, A., Ewen, E., Cerwenka, A., Hengel, H., & Momburg, F. (2016) · European Journal of Immunology · doi:10.1002/eji.201646492 · Cited by 73
Liver-resident NK cells and their potential functions
Peng, H. C., & Sun, R. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.72 · Cited by 69
Memory and Memory-Like NK Cell Responses to Microbial Pathogens
Brillantes, M., & Beaulieu, A. M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00102 · Cited by 69
Taveirne, S., Wahlen, S., Loocke, W. V., Kiekens, L., Persyn, E., Ammel, E. V., Mulder, K. D., Roels, J., Tilleman, L., Aumercier, M., et al. (2020) · Blood · doi:10.1182/blood.2020005204 · Cited by 67
iPSC-Derived Natural Killer Cells for Cancer Immunotherapy
Karagiannis, P., & Kim, S. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0078 · Cited by 69
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications
Vito, C. D., Calcaterra, F., Coianiz, N., Terzoli, S., Voza, A., Mikulak, J., Bella, S. D., & Mavilio, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888248 · Cited by 69
Lachance, C., Gottschalk, M. G., Gerber, P. P., Lemire, P., Xu, J., & Segura, M. (2013) · Infection and Immunity · doi:10.1128/iai.01317-12 · Cited by 69
Gogali, F., Paterakis, G., Rassidakis, G. Z., Liakou, C. I., & Liapi, C. A. (2013) · Thyroid · doi:10.1089/thy.2012.0560 · Cited by 69
on behalf of the Cancer Immunotherapy Trials Network (CITN), Kohrt, H. E. K., Tumeh, P. C., Benson, D., Bhardwaj, N., Brody, J., Formenti, S. C., Fox, B. A., Galon, J., June, C. H., et al. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0118-0 · Cited by 69
Self-citationTumor immunotherapy: New aspects of natural killer cells
Li, Y., & Sun, R. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.02.02 · Cited by 71
NK Cell-Based Immunotherapy for Hematological Malignancies
Sivori, S., Meazza, R., Quintarelli, C., Carlomagno, S., Chiesa, M. D., Falco, M., Moretta, L., Locatelli, F., & Pende, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101702 · Cited by 68
Rezasoltani, S., Yadegar, A., Aghdaei, H. A., & Zali, M. R. (2020) · Cancer Medicine · doi:10.1002/cam4.3694 · Cited by 67
Chrétien, A.-S., Devillier, R., Granjeaud, S., Cordier, C., Demerle, C., Salem, N., Wlosik, J., Orlanducci, F., Gorvel, L., Fattori, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020459118 · Cited by 68
Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
Castillo‐Rodríguez, R. A., Trejo‐Solís, C., Cabrera‐Cano, A., Gómez‐Manzo, S., & Dávila‐Borja, V. M. (2022) · Cancers · doi:10.3390/cancers14092291 · Cited by 70
Hall, L. J., Murphy, C., Quinlan, A., Hurley, G., Shanahan, F., Nally, K., & Melgar, S. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.140 · Cited by 68
The role of natural killer cells in immunity against multiple myeloma
Godfrey, J. K., & Benson, D. M. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.676175 · Cited by 70
Overview of the Killer Cell Immunoglobulin-Like Receptor System
Rajalingam, R. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-842-9_23 · Cited by 74
NK Cells: Uncertain Allies against Malaria
Wolf, A., Sherratt, S., & Riley, E. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00212 · Cited by 67
Dong, W., Li, J., & Zhuang, Z. (2024) · Aging · doi:10.18632/aging.205376 · Cited by 87
NK cell subsets in autoimmune diseases
Zhang, C., & Tian, Z. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.02.005 · Cited by 69
Inflammatory Cytokines, Immune Cells, and Organ Interactions in Heart Failure
Li, H., Chen, C., & Wang, D. W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.695047 · Cited by 73
Cytokine-Mediated Activation of NK Cells during Viral Infection
Freeman, B. E., Raué, H.-P., Hill, A. B., & Slifka, M. K. (2015) · Journal of Virology · doi:10.1128/jvi.00199-15 · Cited by 68
Decreased NK cell functions in obesity can be reactivated by fat mass reduction
Jahn, J., Spielau, M., Brandsch, C., Stangl, G. I., Delank, K.-S., Bähr, I., Berreis, T., Wrann, C. D., & Kielstein, H. (2015) · Obesity · doi:10.1002/oby.21229 · Cited by 67
Chan, W. K., Rujkijyanont, P., Neale, G. A. M., Yang, J., Bari, R., Gupta, N., Holladay, M. S., Rooney, B., & Leung, W. H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300111 · Cited by 67
Role of interleukin-18 in the pathophysiology of allergic diseases
Sanders, N. L., & Mishra, A. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.07.001 · Cited by 67
Evert, J. S. H., Maas, R. J. A., der Meer, J. M. R. V., Cany, J., van der Steen, S., Jansen, J. H., Miller, J. S., Bekkers, R. L. M., Hobo, W. A., Massuger, L. F. A. G., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26199 · Cited by 68
Therapeutic Potential of Natural Killer Cells in Gastric Cancer
Du, Y., & Wei, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03095 · Cited by 67
Structural Basis for Recognition of Cellular and Viral Ligands by NK Cell Receptors
Li, Y., & Mariuzza, R. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00123 · Cited by 68
Katsiougiannis, S., Chia, D., Kim, Y., Singh, R. P., & Wong, D. T. (2016) · The FASEB Journal · doi:10.1096/fj.201600984r · Cited by 66
Elfeky, R., Lazareva, A., Qasim, W., & Veys, P. A. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1612746 · Cited by 66
Multhoff, G., Seier, S., Stangl, S., Sievert, W., Shevtsov, M. A., Werner, C., Pockley, A. G., Blankenstein, C., Hildebrandt, M., Offner, R., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1141 · Cited by 66
Botryllus schlosseri allorecognition: tackling the enigma
Taketa, D. A., & Tomaso, A. W. D. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.03.014 · Cited by 66
NK Cell Subset Redistribution during the Course of Viral Infections
Lugli, E., Marcenaro, E., & Mavilio, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00390 · Cited by 65
Diversification and Functional Specialization of Human NK Cell Subsets
Cichocki, F. M., Schlums, H., Theorell, J., Tesi, B., Miller, J. S., Ljunggren, H., & Bryceson, Y. T. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_487 · Cited by 72
Immunosuppression following dietary aflatoxin B1 exposure: a review of the existing evidence
Mohsenzadeh, M. S., Hedayati, N., Riahi‐Zanjani, B., & Karimi, G. (2016) · Toxin Reviews · doi:10.1080/15569543.2016.1209523 · Cited by 68
Nanomaterials and Innate Immunity: A Perspective of the Current Status in Nanosafety
Cronin, J., Jones, N., Thornton, C. A., Jenkins, G. J. S., Doak, S. H., & Clift, M. J. D. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00051 · Cited by 67
G-protein-coupled receptors in control of natural killer cell migration
Walzer, T., & Vivier, É. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.002 · Cited by 71
Zheng, Y. Z., Zong, Z., Chen, S., Chen, A., & Wei, X. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.11.013 · Cited by 65
Experimental evolution of insect immune memory versus pathogen resistance
Khan, I., Prakash, A., & Agashe, D. (2017) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2017.1583 · Cited by 64
Díaz-Tejedor, A., Lorenzo-Mohamed, M., Puig, N., García‐Sánz, R., Mateos, M., Garayoa, M., & Paíno, T. (2021) · Cancers · doi:10.3390/cancers13061353 · Cited by 66
Defining the role of natural killer cells in COVID-19
Lee, M. J., & Blish, C. A. (2023) · Nature Immunology · doi:10.1038/s41590-023-01560-8 · Cited by 65
Li, J., Ertel, A., Portocarrero, C. P., Barkhouse, D. A., Dietzschold, B., Hooper, D. C., & Faber, M. (2012) · Journal of Virology · doi:10.1128/jvi.06699-11 · Cited by 65
Immune Responses and Lassa Virus Infection
Russier, M., Pannetier, D., & Baize, S. (2012) · Viruses · doi:10.3390/v4112766 · Cited by 65
Respiratory Influenza Virus Infection Induces Memory-like Liver NK Cells in Mice
Li, T., Wang, J., Wang, Y., Chen, Y., Wei, H., Sun, R., & Tian, Z. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502186 · Cited by 65
Raulet, D. H., Marcus, A., & Coscoy, L. (2017) · Immunological Reviews · doi:10.1111/imr.12600 · Cited by 66
Self-citationHeterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua
Vacca, P., Chiossone, L., Mingari, M. C., & Moretta, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00170 · Cited by 69
Novel insights in CAR-NK cells beyond CAR-T cell technology; promising advantages
Ebrahimiyan, H., Tamimi, A., Shokoohian, B., Minaei, N., Memarnejadian, A., Hossein‐Khannazer, N., Hassan, M., & Vosough, M. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108587 · Cited by 64
Grille, S., Moreno, M., Bascuas, T., Marqués, J. M., Muñoz‐Wolf, N., Lens, D., & Chabalgoity, J. A. (2014) · Immunology · doi:10.1111/imm.12320 · Cited by 64
Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells
Torelli, G. F., Peragine, N., Raponi, S., Pagliara, D., Propris, M. S. D., Vitale, A., Bertaina, A., Barberi, W., Moretta, L., Basso, G., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.101931 · Cited by 67
Dupuy, S., Lambert, M., Zucman, D., Choukem, S. P., Tognarelli, S., Pagès, C., Lebbé, C., & Caillat‐Zucman, S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002486 · Cited by 67
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells
Antonangeli, F., Soriani, A., Ricci, B., Ponzetta, A., Benigni, G., Morrone, S., Bernardini, G., & Santoni, A. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1218105 · Cited by 67
Mancusi, A., Ruggeri, L., & Velardi, A. (2016) · Blood · doi:10.1182/blood-2016-07-730564 · Cited by 64
Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
Uppendahl, L. D., Dahl, C. M., Miller, J. S., Felices, M., & Geller, M. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01825 · Cited by 64
Vandenhaute, J., Wouters, C. H., & Matthys, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03089 · Cited by 66
Landscape of natural killer cell activity in head and neck squamous cell carcinoma
Charap, A., Enokida, T., Brody, R., Sfakianos, J. P., Miles, B. A., Bhardwaj, N., & Horowitz, A. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001523 · Cited by 66
The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma
Lospinoso Severini, L., Ghirga, F., Bufalieri, F., Quaglio, D., Infante, P., & Di Marcotullio, L. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1823967 · Cited by 61
TRPML Cation Channels in Inflammation and Immunity
Spix, B., Chao, Y., Abrahamian, C., Chen, C., & Grimm, C. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00225 · Cited by 63
Development of human natural killer cells and other innate lymphoid cells
Montaldo, E., Vacca, P., Moretta, L., & Mingari, M. C. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.006 · Cited by 64
Advances in NKG2D ligand recognition and responses by NK cells
Bert, N. L., & Gasser, S. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2013.111 · Cited by 63
Wang, B., Song, J., Yuan, H., Nie, C., Lv, F., Liu, L., & Wang, S. (2013) · Advanced Materials · doi:10.1002/adma.201304593 · Cited by 63
Seyda, M., Elkhal, A., Quante, M., Falk, C. S., & Tullius, S. G. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.06.004 · Cited by 63
Updates on Management of Adult Medulloblastoma
Majd, N., & Peñas-Prado, M. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0663-0 · Cited by 63
Mikelez-Alonso, I., Magadán, S., González‐Fernández, Á., & Borrego, F. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113860 · Cited by 63
Letafati, A., Ardekani, O. S., Naderisemiromi, M., Norouzi, M., Shafiei, M., Nik, S., & Mozhgani, S. (2024) · Virology Journal · doi:10.1186/s12985-024-02287-0 · Cited by 70
Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer
Vojdani, A., Köksoy, S., Vojdani, E., Engelman, M., Benzvi, C., & Lerner, A. (2024) · Microorganisms · doi:10.3390/microorganisms12010230 · Cited by 64
Weeres, M., Robien, K., Ahn, Y., Neulen, M.-L., Bergerson, R. J., Miller, J. S., & Verneris, M. R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400698 · Cited by 62
Janusek, L. W., Tell, D., Albuquerque, K., & Mathews, H. L. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.014 · Cited by 63
Bozzano, F. M., Marras, F., & Maria, A. D. (2014) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2014.027 · Cited by 64
Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?
Chiesa, M. D., Sivori, S., Carlomagno, S., Moretta, L., & Moretta, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00573 · Cited by 62
Self-citationBlokhuis, J. H., Hilton, H. G., Guethlein, L. A., Norman, P. J., Nemat‐Gorgani, N., Nakimuli, A., Chazara, O., Moffett, A., & Parham, P. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.178 · Cited by 62
Metadata
- Authors
- Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S.
- Affiliations
- Centre d’Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée UM 631, Campus de Luminy, 13288 Marseille, France.
- University of California, Berkeley (US)
- University of Genoa (IT)
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- Inserm (FR)
- University of California, San Francisco (US)
- Howard Hughes Medical Institute (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Raulet, David H.
- Moretta, Alessandro
- Caligiuri, Michael A.
- Zitvogel, Laurence
- Lanier, Lewis L.
- Yokoyama, Wayne M.
- Ugolini, Sophie
- ORCID
- Venue
- Science
- Published
- 2011-01-07
- Volume
- 331
- Issue
- 6013
- Pages
- 44-49
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3089969
- OpenAlex
- W2146313292
- Cited by
- 2,824
- References
- 78
- Citations by year
- 2026: 133 · 2025: 147 · 2024: 158 · 2023: 142 · 2022: 215 · 2021: 211 · 2020: 222 · 2019: 205 · 2018: 176 · 2017: 211 · 2016: 176 · 2015: 191 · 2014: 199 · 2013: 200 · 2012: 150
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (R01CA093678, R01CA095137, P01CA095426, CA095137, CA16058, CA 68458, CA95426, CA093678, P30CA016058)
- National Institute of Allergy and Infectious Diseases (AI-068129, R01AI068129, AI51345, R37AI066897, AI039642, AI34385, R01AI033903, AI5716, R01AI051345, AI-33903, R01AI039642, AI066897, R01AI035021, AI035021, P30AI027763)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- natural killer cells, innate immunity, adaptive immunity, NK cell receptors, activating and inhibitory receptors, self-tolerance, cytotoxicity, viral infection, antitumor immunity, immunological memory
- MeSH terms
- Animals, Humans, Immunity, Innate, Immunologic Memory, Killer Cells, Natural, Neoplasms, Receptors, Immunologic, Virus Diseases, Self Tolerance, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
